Skip to main content

Advertisement

Table 3 A cross-study comparison of long term survival data and early death rates of the patients with HNSCC from Basel and patients with HNSCC who had been treated within published clinical trials with concurrent chemo-radiotherapy

From: Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality

Study Year 3-OS (in %) 5-OS (in %) Early mortality (patients)
Bonner et. al. 2006 55 40* 11/211 (5%)
Huguenin et. al. 2004 59° 46 0/112 (0%)
Calais et. al. 1999 51 - 1/109 (1%)
Merlano et. al. 1996 38* 24 not reported
Adelstein et. al. 2000 37 28* 6/96 (6%)
Wendt et. al. 1998 49 - 4/256 (2%)
Brizel et. al. 1998 55 48* 1/56 (2%)
Al-Sarraf et. al. 1998 78 68* 1/78 (1%)
Data from Basel 1994-2007 54 47 9/167 (5%)
- Therapy before 2000   43 33  
- Therapy after 2000   65 61  
  1. °Survival after 2.5 years.
  2. *estimated value.